Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02730039 · ClinicalTrials.gov registry record
Meaning-Centered Psychotherapy Training for Cancer Care Providers
A clinical trial of Cancer Care Providers, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 350
- Enrollment target
- 1
- Study location
NCT02730039: Active study of Cancer Care Providers, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02730039 is a study of Cancer Care Providers that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 350 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02730039, a study of Cancer Care Providers, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project, entitled "Meaning-Centered Psychotherapy Training for Cancer Care Providers," is to develop a multi-modal training program in Meaning-Centered Psychotherapy (MCP) for multidisciplinary cancer care clinicians who provide psycho-oncology and psychosocial palliative care services for cancer patients.
Primary Outcome
Evaluation will take place on two levels, as data will be collected directly from: 1) MCPT participants and 2) MCP trainers. Data on the training will be collected before and during the MCPT session. Data on post-MCP training will be collected for one year following participation in the MCPT.
Conditions Studied
Interventions
- BEHAVIORAL assessments
- BEHAVIORAL workshop
- BEHAVIORAL follow-up calls & webinars
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2015-12-11 |
| Est. Completion | 2026-12-11 |
What the registry record for NCT02730039 still lists
NCT02730039 is an observational study that tracks outcomes without assigning an intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Cancer Care Providers appearing as the primary indexed condition, and to 3 interventions - of which assessments is the first listed.
NCT02730039 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02730039 about?
NCT02730039 is a clinical study titled "Meaning-Centered Psychotherapy Training for Cancer Care Providers". The purpose of this project, entitled "Meaning-Centered Psychotherapy Training for Cancer Care Providers," is to develop a multi-modal training program in Meaning-Centered Psychotherapy (MCP) for multidisciplinary cancer care clinicians who provide psycho-oncology and psychosocial palliative care se...
What is the current status of trial NCT02730039?
This trial is currently active not recruiting. The enrollment target is 350 participants. The study started on 2015-12-11. Estimated completion is 2026-12-11.
What conditions does trial NCT02730039 study?
This clinical trial studies the following conditions: Cancer Care Providers.
What interventions are being tested in trial NCT02730039?
The interventions under investigation include: assessments (BEHAVIORAL), workshop (BEHAVIORAL), follow-up calls & webinars (BEHAVIORAL).
Who is sponsoring clinical trial NCT02730039?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02730039 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI